Yahanda Alexander T, Simon Laura E, Limbrick David D
Departments of1Neurological Surgery and.
2Washington University School of Medicine, St. Louis, Missouri.
J Neurosurg. 2021 Apr 9;135(5):1356-1369. doi: 10.3171/2020.9.JNS202641. Print 2021 Nov 1.
Posterior fossa decompression with duraplasty (PFDD) is often used for Chiari malformation type I (CM-I), but outcomes associated with different dural graft materials are not well characterized. In this meta-analysis, the authors examined complication rates and outcomes after PFDD for CM-I for autografts and four types of nonautologous grafts.
A literature search of numerous electronic databases (Ovid Medline, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, Health Technology Assessment Database, NHS Economic Evaluation Database, and ClinicalTrials.gov) was performed to identify articles detailing complications for dural graft materials after PFDD. Whenever available, data were also extracted regarding the need for revision surgery, symptom changes after PFDD, and syrinx size changes after PFDD. All searches were compliant with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), Institute of Medicine, Standards for Systematic Reviews, Cochrane Handbook for Systematic Reviews of Interventions, and Peer Review of Electronic Search Strategies guidelines. There were no exclusion criteria based on patient age or presence or absence of syringomyelia.
The current evidence surrounding outcomes for various dural graft materials was found to be of low or very low quality. Twenty-seven studies were included, encompassing 1461 patients. Five types of dural graft materials were included: autograft (n = 404, 27.6%), synthetic (n = 272, 18.6%), bovine pericardium (n = 181, 12.4%), collagen-based (n = 397, 27.2%), and allograft (n = 207, 14.2%). Autograft was associated with a significantly lower rate of pseudomeningocele compared to collagen-based grafts, allografts, and nonautologous grafts in aggregate. Autograft was also associated with the lowest rates of aseptic meningitis, infectious meningitis, and need for revision PFDD, though these associations did not reach statistical significance. No other graft comparisons yielded significant results. Autograft and nonautologous graft materials yielded similar rates of revision surgery and produced similar improvements in postoperative symptoms and syrinx size.
Autograft was the dural graft material that most frequently had the lowest rate of complications and was associated with significantly lower rates of pseudomeningocele compared to collagen-based graft, allograft, and nonautologous graft materials. Autografts and nonautologous grafts yielded similar outcomes for revision surgery, symptoms, and syrinx size. Large prospective studies comparing different graft materials are needed to accurately and precisely characterize outcomes for individual graft types.
后颅窝减压并硬脑膜成形术(PFDD)常用于治疗I型Chiari畸形(CM-I),但不同硬脑膜移植材料相关的疗效尚未得到充分描述。在这项荟萃分析中,作者研究了自体移植和四种非自体移植材料在PFDD治疗CM-I后的并发症发生率和疗效。
对众多电子数据库(Ovid Medline、Embase、Scopus、Cochrane系统评价数据库、Cochrane对照试验中心注册库、效果评价摘要数据库、卫生技术评估数据库、NHS经济评估数据库和ClinicalTrials.gov)进行文献检索,以确定详细描述PFDD后硬脑膜移植材料并发症的文章。只要有可用数据,还提取了关于翻修手术需求、PFDD后症状变化以及PFDD后脊髓空洞大小变化的数据。所有检索均符合系统评价和荟萃分析的首选报告项目(PRISMA)、医学研究所、系统评价标准、Cochrane干预措施系统评价手册以及电子检索策略同行评审指南。没有基于患者年龄或是否存在脊髓空洞症的排除标准。
目前关于各种硬脑膜移植材料疗效的证据质量低或非常低。纳入了27项研究,共1461例患者。包括五种硬脑膜移植材料:自体移植(n = 404,27.6%)、合成材料(n = 272,18.6%)、牛心包(n = 181,12.4%)、胶原基材料(n = 397,27.2%)和同种异体移植(n = 207,14.2%)。与胶原基移植、同种异体移植和非自体移植材料总体相比,自体移植的假性脑膜膨出发生率显著更低。自体移植的无菌性脑膜炎、感染性脑膜炎发生率以及翻修PFDD的需求率也最低,尽管这些关联未达到统计学显著性。其他移植材料比较未产生显著结果。自体移植和非自体移植材料的翻修手术率相似,术后症状和脊髓空洞大小的改善也相似。
自体移植是最常出现并发症发生率最低的硬脑膜移植材料,与胶原基移植、同种异体移植和非自体移植材料相比,其假性脑膜膨出发生率显著更低。自体移植和非自体移植在翻修手术、症状和脊髓空洞大小方面的疗效相似。需要进行大型前瞻性研究来准确和精确地描述不同移植材料的疗效。